Luke Eivers
Impact in
-
- Venous Thromboembolism Diagnosis and Management
-
- Platelet Disorders and Treatments
Papers in
-
- Platelet Disorders and Treatments 1
-
- Atherosclerosis and Cardiovascular Diseases 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Immune cells in cancer 2
- Co-authors
- Imtiyaz Yaseen (1 shared paper)Robin C. Allshire (1 shared paper)Yizhi Cai (1 shared paper)Baptiste Gaborieau (1 shared paper)Alison L. Pidoux (1 shared paper)Sharon A. White (1 shared paper)Irene Schubert (1 shared paper)Sue Chandraratne (1 shared paper)
- Journals
- Immunity (2 papers)Blood (2 papers)Nature Communications (1 paper)Wellcome Open Research (1 paper)Nature Medicine (1 paper)
- Partner nations
- GermanyUnited KingdomNetherlands
In The Last Decade
Luke Eivers
9 papers receiving 235 citations
Peers
Comparison fields: 5 of 56
- Internal Medicine 20
- Hematology 47
- Immunology 58
- Immunology and Allergy 7
- Molecular Biology 79
Countries citing papers authored by Luke Eivers
This map shows the geographic impact of Luke Eivers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Eivers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Eivers more than expected).
Fields of papers citing papers by Luke Eivers
This network shows the impact of papers produced by Luke Eivers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Eivers. The network helps show where Luke Eivers may publish in the future.
Co-authors
The 14 scholars most cited alongside Luke Eivers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 49 | |
| 2 | 2024 | 35 | |
| 3 | 2020 | 35 | |
| 4 | 2023 | 34 | |
| 5 | 2024 | 28 | |
| 6 | 2022 | 23 | |
| 7 | 2025 | 17 | |
| 8 | 2024 | 14 | |
| 9 | 2023 | 3 |
About Luke Eivers
Luke Eivers is a scholar working on Hematology, Immunology, Internal Medicine, Immunology and Allergy and Emergency Medicine, having authored 9 papers that have together received 238 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Immune cells in cancer (2 papers), CRISPR and Genetic Engineering (1 paper), COVID-19 Clinical Research Studies (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Cell Adhesion Molecules Research (1 paper) and Platelet Disorders and Treatments (1 paper). The work is most often cited by research in Internal Medicine (20 citations), Hematology (47 citations), Immunology (58 citations), Immunology and Allergy (7 citations) and Molecular Biology (79 citations). Luke Eivers has collaborated with scholars based in Germany, United Kingdom and Netherlands. Frequent co-authors include Imtiyaz Yaseen, Robin C. Allshire, Yizhi Cai, Baptiste Gaborieau, Alison L. Pidoux, Sharon A. White, Irene Schubert, Sue Chandraratne, Ilka Ott and Marie-Luise von Brühl. Their work appears in journals such as Immunity, Blood, Nature Communications, Wellcome Open Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.